Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Varbella

Showing results (221-230 of 224) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 224 results.
European Journal of Preventive Cardiology|May 24, 2024
Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registryPaola Gargiulo, Christian Basile, Gennaro Galasso, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Journal of Neurology|December 3, 2014
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 studyMaurizio Paciaroni, Domenico Inzitari, Giancarlo Agnelli, et al.
Giornale Italiano Di Cardiologia (2006)|August 9, 2018
[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation]Giuseppe Tarantini, Giovanni Esposito, Giuseppe Musumeci, et al.
Pageof 23

Showing results (221-230 of 224) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 224 results.
European Journal of Preventive Cardiology|May 24, 2024
Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registryPaola Gargiulo, Christian Basile, Gennaro Galasso, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Journal of Neurology|December 3, 2014
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 studyMaurizio Paciaroni, Domenico Inzitari, Giancarlo Agnelli, et al.
Giornale Italiano Di Cardiologia (2006)|August 9, 2018
[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation]Giuseppe Tarantini, Giovanni Esposito, Giuseppe Musumeci, et al.
Pageof 23